Gavin Wood is Chief Financial Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 96,000 shares of ADAP, which is worth approximately $57,600. The most recent transaction as insider was on May 20, 2022, when has been sold 39,000 shares (Ordinary Shares with a nominal value of GBP0.001 per share) at a price of $0.29 per share, resulting in proceeds of $11,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96K
0% 3M change
0% 12M change
Total Value Held $57,600

Gavin Wood Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Open market or private purchase
$11,310 $0.29 p/Share
39,000 Added 28.89%
96,000 Ordinary Shares with a...
Dec 14 2020
BUY
Open market or private purchase
$16,560 $0.69 p/Share
24,000 Added 29.63%
57,000 Ordinary Shares with a...
GW

Gavin Wood

Chief Financial Officer
Abingdon, X0

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Track Activities on ADAP